Cannabis-based compositions for the treatment of autistic spectrum disorders
AssigneeTo Pharmaceuticals LLC
InventorsLihi BAR-LEV SCHLEIDER, Sid TAUBENFELD
Life of this patent
Estimating the term…
Abstract
Provided are therapeutic products and methods applicable to the treatment of patients with autistic spectrum disorder (ASD) or partial symptoms of ASD, said the products and methods using certain cannabis-based compositions enriched in CBD with a minimum content of THC under specific regimens and types of administration.
Claims18
-26. (canceled)
A method for treating an autistic spectrum disorder (ASD), or alleviating or reducing at least one symptom of an ASD in a subject suffering therefrom, the method comprising administering to the subject a therapeutically effective amount of a cannabis-based composition comprising Cannabidiol to Tetrahydrocannabinol ratio (CBD:THC) of at least about 20:1, respectively (w/w).
Dependencies are inferred from the claim text.